What is a biobank and what it serves for?
Biobanking is when remaining (Residual, according to the Belgian law of 19 December 2008, modified on March 19th, 2013 and April 10th, 2014) or extra tissue that has been removed during a medical procedure, such as an operation, biopsy or blood test is collected and stored. Biobanks play a crucial role in biomedical research. Researchers access biobanks when they are in need of specimens for their research studies.
Most importantly, biobanks help scientists to study cancer biology which could be vital and can lead to earlier, more accurate diagnosis and better treatment. Furthermore, it helps in developing new cancer drugs, diagnostic tests and potential biomarkers that predict the prognosis and response to treatment.
The IPG-Biobank was initiated by the Institute of Pathology and Genetics (IPG, Gosselies) and his partner hospitals. The Biobank is located at the Institute of Pathology and Genetics in modern purpose built facilities and is funded by the federal cancer plan. The institute is specialized in medical diagnosis related to anatomopathology, genetics, molecular biology and microbiology. More than 200 people (including 21 anatomopathologists and 9 geneticists) provide almost 300,000 specialized analyses every year, collaborating with more than 20 hospitals, in agreement with Belgian government prescriptions. The IPG has been accreditated ISO 15189.
The IPG-Biobank is a large multi-center collection facilities, collecting tissues and blood from donors at 4 main hospitals in Wallonia. The Biobank provides a coordinated and integrated program that collects and distributes tissue samples to support cancer research in Belgium with the aim of delivering better clinical outcomes to people with cancer. The BioBank is also the home for a number of valuable serum, plasma, DNA and RNA samples collected from patients with a variety of cancer types.
High-quality biomaterial is supplied for our Biobank by a network of clinicians, surgeons and pathologists.
All patient donations are given with informed consent and all areas of operation are governed by strict standard operating procedures with appropriate quality control measures. The tissues are conserved in a secure environment according to strict criteria and procedures.
We currently hold biomaterials from different disease and cancer areas including:
Research is supported by anonymised medical information in the form of a non-identifiable donor data set, which includes:
Biobank coordinator: Paul Delrée, MD, PhD, Tel: 0032 (0) 71 34 71 63, Email: email@example.com
Biobank Manager: Ahmad Merhi, PhD, Tel: 0032 (0) 71 34 78 50, Email: firstname.lastname@example.org